An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder
18h agoen
From the article
Conditions : Obesity; Methamphetamine Use Disorder; Cocaine Use Disorder; Stimulant Use Disorders Interventions : Drug: Tirzepatide Sponsors : University of Texas Southwestern Medical Center Not yet recruiting
Continue reading on clinicaltrials.govYou might also wanna read
GLP-1 drugs show early promise for treating substance use disorders, but evidence remains preliminary
GLP-1 receptor agonists (like semaglutide and tirzepatide), already transformative for obesity and diabetes, are being investigated as a pot
mdsc.pe·6d ago
Tirzepatide
twc.health·9d agoTirzepatide
twc.health·9d ago
Causes and consequences of discontinuation of GLP1RAs or tirzepatide
doi.org·16d ago
GLP-1 Medications Show Promise for Treating Addiction Through Brain Reward Pathways
The article explores the emerging potential of GLP-1 medications like Ozempic to treat various addictions beyond their original diabetes and
newyorker.com·5mo agoUn estudio siguió a personas con prediabetes durante 21 años y encontró algo mejor que una pastilla
afsdp.org.pe·23h ago
Unicamp analysis confirms Paraguayan weight-loss pens contain tirzepatide, the active ingredient in Mounjaro
An independent analysis by Unicamp researchers, commissioned by Folha, found that weight-loss pens manufactured in Paraguay and sold as vers
www1.folha.uol.com.br·5d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.